Twice-Yearly HIV Jab: Activists Call for Lower Prices

Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged AIDS, Drug Accessibility, Gilead Sciences, Health Activism, Health Justice Initiative, HIV, lenacapavir, Pharmaceutical, Pre-Exposure Prophylaxis, PrEP, Public Health, SAHPRA, South Africa, UNAIDS, Yetzugo